---
title: "Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290195074.md"
description: "US stock futures rose, with Nasdaq futures up over 1%. Legend Biotech (LEGN) shares fell 9% in pre-market trading after pricing a $226 million public offering of 7.7 million ADSs at $29.35 each. Sleep Number (SNBR) plummeted nearly 50% to $0.20 due to impending Nasdaq delisting following its Chapter 11 bankruptcy. Other stocks like SLBT, RERE, and SGMT also declined significantly in early trading."
datetime: "2026-06-18T12:02:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290195074.md)
  - [en](https://longbridge.com/en/news/290195074.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290195074.md)
generator: "portal-rs"
---

# Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 1% on Thursday.

Shares of **Legend Biotech Corp** (NASDAQ:LEGN) fell sharply in pre-market trading after the company announced the pricing of public offering.

Legend Biotech priced a public offering of 7.7 million ADSs at $29.35 per ADS, raising gross proceeds of $226 million.

Legend Biotech shares dipped 9% to $30.50 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

-   **Sleep Number Corp** (NASDAQ:SNBR) tumbled 49.7% to $0.20 in pre-market trading after company disclosed that Nasdaq plans to delist its common stock following the mattress maker's recent Chapter 11 bankruptcy filing.
-   **SL Science Holding Ltd** (NASDAQ:SLBT) shares dipped 16.7% to $5.31 in pre-market trading after falling 28% on Wednesday.
-   **ATRenew Inc** (NYSE:RERE) shares fell 10.8% to $3.54 in pre-market trading.
-   **Sagimet Biosciences Inc** (NASDAQ:SGMT) declined 8.1% to $6.00 in pre-market trading after gaining around 4% on Wednesday.
-   **Pangaea Logistics Solutions Ltd** (NASDAQ:PANL) fell 6.2% to $7.00 in pre-market trading.
-   **Braiin Ltd** (NASDAQ:BRAI) dipped 5.3% to $8.86 in pre-market trading. Braiin announced a partnership with BillCentral to deploy its Agentic AI-powered customer experience and call center platform across enterprise platforms.
-   **Liberty Energy Inc** (NYSE:LBRT) declined 5.2% to $25.76 in pre-market trading.
-   **Acadian Asset Management Inc** (NYSE:AAMI) declined 4.7% to $78.81 in pre-market trading.
-   **Himalaya Shipping Ltd** (NYSE:HSHP) fell 4.5% to $13.65 in pre-market trading.
-   **Sigma Lithium Corp** (NASDAQ:SGML) fell 3.7% to $14.25 in pre-market trading.

*Photo via Shutterstock*

### Related Stocks

- [LEGN.US](https://longbridge.com/en/quote/LEGN.US.md)
- [SNBR.US](https://longbridge.com/en/quote/SNBR.US.md)
- [RERE.US](https://longbridge.com/en/quote/RERE.US.md)
- [SGMT.US](https://longbridge.com/en/quote/SGMT.US.md)
- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)
- [SNBRQ.US](https://longbridge.com/en/quote/SNBRQ.US.md)
- [PANL.US](https://longbridge.com/en/quote/PANL.US.md)
- [BRAI.US](https://longbridge.com/en/quote/BRAI.US.md)
- [LBRT.US](https://longbridge.com/en/quote/LBRT.US.md)
- [AAMI.US](https://longbridge.com/en/quote/AAMI.US.md)
- [HSHP.US](https://longbridge.com/en/quote/HSHP.US.md)
- [SGML.US](https://longbridge.com/en/quote/SGML.US.md)

## Related News & Research

- [Legend Biotech CEO Alan Bash joins Morgan Stanley Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297649230.md)
- [Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?](https://longbridge.com/en/news/296957090.md)
- [Want More Income From Large-Cap Stocks? XFUNDS Bets on Options With New VOOY ETF](https://longbridge.com/en/news/297825700.md)
- [Nokia Stock And 2 Quality Large Caps for Calmer Markets](https://longbridge.com/en/news/297408414.md)
- [TD Cowen Sticks to Its Hold Rating for Legend Biotech (LEGN)](https://longbridge.com/en/news/295580007.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**